Patel Aditya, Doss Shawn, Anche Gowtham, Duncan Irielle, Anderson Daniel, Yue Patrick, Huggett Ashley
Division of Infectious Diseases, Augusta University Medical College of Georgia, Augusta, USA.
Department of Internal Medicine, Touro College of Osteopathic Medicine, New York, USA.
Cureus. 2025 May 1;17(5):e83292. doi: 10.7759/cureus.83292. eCollection 2025 May.
(), a dimorphic fungus endemic to the Mississippi and Ohio River Valleys, is a rare cause of fungal infective endocarditis. Here, we present a case of prosthetic valve endocarditis due to diagnosed via microbial cell-free DNA (cfDNA) sequencing when traditional methods, such as urine antigen and blood cultures, fail. A 56-year-old male patient with a history of a bioprosthetic mitral valve replacement presented with chest pain, confusion, and constitutional symptoms. Initial laboratory results, negative blood cultures, and echocardiographic findings were consistent with a diagnosis of culture-negative endocarditis. To identify a potential pathogen not detected by blood cultures, both urine antigen testing and the Karius Test®, a next-generation sequencing-based cfDNA assay, were performed concurrently. While traditional methods, including blood cultures and urine antigen testing, were negative, the Karius Test® identified , prompting initiation of antifungal therapy. The patient subsequently showed clinical improvement, evidenced by the resolution of symptoms and a reduction in the size of the valvular lesion. This case highlights the diagnostic challenges of fungal endocarditis and underscores the utility of cfDNA sequencing in identifying elusive pathogens when conventional tests are inconclusive. Early recognition and targeted antifungal therapy are crucial for improving patient outcomes in culture-negative endocarditis cases.
()是一种密西西比河和俄亥俄河流域特有的双相真菌,是真菌性感染性心内膜炎的罕见病因。在此,我们报告一例人工瓣膜心内膜炎病例,该病例由[真菌名称]引起,当传统方法如尿抗原检测和血培养失败时,通过微生物游离DNA(cfDNA)测序得以确诊。一名有生物人工二尖瓣置换史的56岁男性患者出现胸痛、意识模糊和全身症状。初步实验室检查结果、血培养阴性以及超声心动图检查结果均符合培养阴性的心内膜炎诊断。为了确定血培养未检测到的潜在病原体,同时进行了尿[真菌名称]抗原检测和Karius Test®(一种基于下一代测序的cfDNA检测方法)。虽然包括血培养和尿抗原检测在内的传统方法均为阴性,但Karius Test®检测出了[真菌名称],促使开始抗真菌治疗。患者随后临床症状改善,症状缓解以及瓣膜病变大小减小证明了这一点。该病例突出了真菌性心内膜炎的诊断挑战,并强调了在传统检测无定论时cfDNA测序在识别难以捉摸的病原体方面的实用性。早期识别和针对性抗真菌治疗对于改善培养阴性的心内膜炎病例的患者预后至关重要。